Historique
Article de Périodique
Continued signs of resilience in the European drug market: Highlights from the EMCDDA's 2016 European drug report (2016)
Auteur(s) :
MOUNTENEY, J. ;
GRIFFITHS, P. ;
CUNNINGHAM, A. ;
EVANS-BROWN, M. ;
FERRI, M. ;
HEDRICH, D. ;
NOOR, A.
Année
2016
Page(s) :
492-495
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Organismes
OEDT
Thésaurus géographique
EUROPE
Thésaurus mots-clés
MDMA-ECSTASY
;
MARCHE DE LA DROGUE
;
INTERNET
;
CANNABIS
;
DROGUES DE SYNTHESE
;
MORTALITE
Résumé :
May 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and individual country information (EMCDDA, 2016a). As in previous years (Mounteney & Griffiths, 2014; Mounteney, Zobel, & Griffiths, 2013), we present highlights from the report which can be accessed in its entirety at: www.emcdda.europa.eu. Overall, the 2016 analysis highlights a resilient European drug market, with recent survey data showing modest increases in the estimated prevalence of use of cannabis and stimulant drugs and the purity or potency levels of most illicit substances either high or increasing. [Extract]
Affiliation :
EMCDDA, Lisbon, Portugal
- voir aussi :
Cote :
Abonnement